Insider Transactions in Q3 2025 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2025
|
Wayne Markowitz CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-3.46%
|
$50,050
$77.57 P/Share
|
|
Sep 13
2025
|
Andrew M. Dahl SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-3.2%
|
$20,174
$77.57 P/Share
|
|
Sep 11
2025
|
Daveen Chopra CVP, TMTT & Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
3,205
+8.57%
|
-
|
|
Sep 11
2025
|
Wayne Markowitz CVP, JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
6,410
+25.43%
|
-
|
|
Aug 25
2025
|
Daveen Chopra CVP, TMTT & Surgical |
SELL
Open market or private sale
|
Direct |
2,500
-7.46%
|
$202,500
$81.95 P/Share
|
|
Aug 18
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,950
-4.15%
|
$698,100
$78.06 P/Share
|
|
Aug 18
2025
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,950
+3.98%
|
$528,050
$59.26 P/Share
|
|
Jul 28
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
4,114
-15.75%
|
$325,006
$79.46 P/Share
|
|
Jul 11
2025
|
Annette Bruls CVP, EMEACLA |
SELL
Payment of exercise price or tax liability
|
Direct |
109
-0.76%
|
$8,502
$78.8 P/Share
|
|
Jul 07
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-1.26%
|
$25,308
$76.79 P/Share
|